On September 1, the United States Pharmacopeia (USP) issued a long-awaited Notice of Intent to Revise (NITR) for both USP <795> and USP <797>. In this webinar, our compounding compliance expert Annie Lambert, PharmD, BCSCP will:
- Provide a summary of key changes in the newest revisions to both USP <795> and <797>
- Give an update on issues discussed at the September stakeholder forums
- Present action steps for assessing the potential impact on your compounding practice.